|
|
 Previous Article | Table of Contents | Next Article 
Increased Enzymatic Activity of the T-Cell Antigen Receptor-Associated Fyn Protein Tyrosine Kinase in Asymptomatic Patients Infected With the Human Immunodeficiency Virus
David J. Phipps,
Shida Yousefi, and
Donald R. Branch
From the Department of Oncology Research, The Toronto Hospital Research Institute, the Department of Medicine, University of Toronto; and The Canadian Red Cross Society, Toronto, Ontario, Canada.
The immune system of patients infected with human immunodeficiency virus (HIV) is in a state of chronic activation; however, the nature of HIV-related immune activation is unknown. As normal T-cell activation involves early tyrosine phosphorylation induced by the T-cell antigen receptor-associated src-family protein tyrosine kinase p59fyn(T) (Fyn), we examined a potential role for this kinase in HIV-related immune dysfunction. We determined the relative specific kinase activity of Fyn in lysates of peripheral blood mononuclear cells from 47 normal control individuals tested negative for HIV-1 and -2, human T-cell lymphotropic virus Type I, hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis; 14 asymptomatic HIV-infected patients having near-normal CD4+ T-cell counts (350 to 980 CD4+ cells/µL); 4 patients with symptomatic acquired immunodeficiency syndrome (AIDS) (<30 CD4+ cells/µL); 13 patients having chronic infection with HBV (6 patients) or HCV (7 patients); and 6 patients with systemic lupus erythematosis (SLE). All patients with asymptomatic HIV disease were shown to have a profound increase (mean increase of 19-fold; range threefold to 56-fold increase; p = 1.33 × 10-9) in the relative specific kinase activity of Fyn compared to uninfected controls or patients with hepatitis or SLE. In contrast, patients with AIDS had an Fyn-specific kinase activity that was much less affected (mean increase of threefold; range onefold to sevenfold increase; p = 1.30 × 10-5). It was further shown that HIV infection affects the Fyn-specific kinase activity in CD8+-enriched cells, suggesting abnormal Fyn activity in both CD8+ as well as CD4+ T lymphocytes. Initial results implicate a role for the CSK protein tyrosine kinase as responsible for the abnormal Fyn kinase activity observed in HIV-infected patients. These data indicate early and chronic activation of Fyn as a unique HIV-related effect that has the potential to be diagnostic for early HIV infection and/or may serve as a prognostic indicator for advancement to full-blown AIDS. More importantly, sustained activation of the protein tyrosine kinase associated with T-cell antigen receptor function may result in, or contribute to, the immunopathogenic effects associated with HIV infection.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3603-3612
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Neron, G. Suck, X.-Z. Ma, D. Sakac, A. Roy, Y. Katsman, N. Dussault, C. Racine, and D. R. Branch
B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase
Int. Immunol.,
February 1, 2006;
18(2):
375 - 387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Clark, S. Repping, N. G. Pakker, J. M. Prins, D. W. Notermans, F. W. N. M. Wit, P. Reiss, S. A. Danner, R. A. Coutinho, J. M. A. Lange, et al.
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy
Blood,
July 1, 2000;
96(1):
242 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E. Andoniou, N. L. Lill, C. B. Thien, M. L. Lupher Jr., S. Ota, D. D. L. Bowtell, R. M. Scaife, W. Y. Langdon, and H. Band
The Cbl Proto-Oncogene Product Negatively Regulates the Src-Family Tyrosine Kinase Fyn by Enhancing Its Degradation
Mol. Cell. Biol.,
February 1, 2000;
20(3):
851 - 867.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Kaufman, F. Andris, and O. Leo
A logical analysis of T cell activation and anergy
PNAS,
March 30, 1999;
96(7):
3894 - 3899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
